Kazazian Asset Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.87M Buy
526,554
+7,400
+1% +$30.3K 2.04% 12
2025
Q4
$2.45M Sell
519,154
-20,000
-4% -$89.1K 2.58% 7
2025
Q3
$2.58M Sell
539,154
-121,000
-18% -$476K 3.12% 7
2025
Q2
$1.59M Sell
660,154
-52,404
-7% -$129K 2.19% 11
2025
Q1
$1.86M Buy
+712,558
New +$2.3M 1.51% 14

Other funds holding MSOS

Kazazian Asset Management's MSOS Position: Q1 2026 in Review

Kazazian Asset Management increased its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 1.4% in Q1 2026, buying an estimated $30.3K and bringing the position to 526,554 shares worth $1.87M. The position accounts for 2.04% of the portfolio, ranked #12.

Kazazian Asset Management first reported a position in MSOS in Q1 2025 and has held it in 5 quarters since. The position peaked at $2.58M in Q3 2025. 168 funds tracked by Wall St. Rank hold MSOS as of Q1 2026.

  • Kazazian Asset Management held 526,554 shares of AdvisorShares Pure US Cannabis ETF worth $1.87M as of Q1 2026.
  • Kazazian Asset Management bought 7,400 AdvisorShares Pure US Cannabis ETF shares in Q1 2026, an estimated $30.3K.
  • AdvisorShares Pure US Cannabis ETF made up 2.04% of Kazazian Asset Management's portfolio in Q1 2026, its #12 holding.
  • Kazazian Asset Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2025 and has held it in 5 quarters since.
  • Kazazian Asset Management's AdvisorShares Pure US Cannabis ETF position peaked at $2.58M in Q3 2025.
  • 168 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q1 2026.

Based on Kazazian Asset Management's 13F filing for Q1 2026, filed 12 May 2026.